446 related articles for article (PubMed ID: 29182497)
1. Effect of Prophylactic Human Papillomavirus (HPV) Vaccination on Oral HPV Infections Among Young Adults in the United States.
Chaturvedi AK; Graubard BI; Broutian T; Pickard RKL; Tong ZY; Xiao W; Kahle L; Gillison ML
J Clin Oncol; 2018 Jan; 36(3):262-267. PubMed ID: 29182497
[TBL] [Abstract][Full Text] [Related]
2. Vaccine Effectiveness Against Prevalent Anal and Oral Human Papillomavirus Infection Among Men Who Have Sex With Men-United States, 2016-2018.
Meites E; Winer RL; Newcomb ME; Gorbach PM; Querec TD; Rudd J; Collins T; Lin J; Moore J; Remble T; Swanson F; Franz J; Bolan RK; Golden MR; Mustanski B; Crosby RA; Unger ER; Markowitz LE
J Infect Dis; 2020 Nov; 222(12):2052-2060. PubMed ID: 32504091
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction.
Chandler E; Ding L; Gorbach P; Franco EL; Brown DA; Widdice LE; Bernstein DI; Kahn JA
J Adolesc Health; 2018 Jul; 63(1):43-49. PubMed ID: 30060856
[TBL] [Abstract][Full Text] [Related]
4. National prevalence of oral HPV infection and related risk factors in the U.S. adult population.
Sanders AE; Slade GD; Patton LL
Oral Dis; 2012 Jul; 18(5):430-41. PubMed ID: 22251072
[TBL] [Abstract][Full Text] [Related]
5. Barrier use during oro-genital sex and oral Human Papillomavirus prevalence: Analysis of NHANES 2009-2014.
Gupta A; Perkins RB; Ortega G; Feldman S; Villa A
Oral Dis; 2019 Mar; 25(2):609-616. PubMed ID: 30367525
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men.
Gerend MA; Madkins K; Phillips G; Mustanski B
Sex Transm Dis; 2016 Mar; 43(3):185-91. PubMed ID: 26859806
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Genital Human Papillomavirus Infection and Human Papillomavirus Vaccination Rates Among US Adult Men: National Health and Nutrition Examination Survey (NHANES) 2013-2014.
Han JJ; Beltran TH; Song JW; Klaric J; Choi YS
JAMA Oncol; 2017 Jun; 3(6):810-816. PubMed ID: 28114440
[TBL] [Abstract][Full Text] [Related]
8. Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis.
Closson K; Karim ME; Sadarangani M; Naus M; Ogilvie GS; Donken R
Vaccine; 2020 Dec; 38(52):8396-8404. PubMed ID: 33239227
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Oral Human Papillomavirus Infection Among Young Men Who Have Sex With Men-2 Cities, United States, 2012-2014.
Oliver SE; Gorbach PM; Gratzer B; Steinau M; Collins T; Parrish A; Kerndt PR; Crosby RA; Unger ER; Markowitz LE; Meites E
Sex Transm Dis; 2018 Oct; 45(10):660-665. PubMed ID: 30204745
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of oral HPV infection in the United States, 2009-2010.
Gillison ML; Broutian T; Pickard RK; Tong ZY; Xiao W; Kahle L; Graubard BI; Chaturvedi AK
JAMA; 2012 Feb; 307(7):693-703. PubMed ID: 22282321
[TBL] [Abstract][Full Text] [Related]
11. Assessment of herd effects among women and heterosexual men after girls-only HPV16/18 vaccination in the Netherlands: A repeated cross-sectional study.
Woestenberg PJ; Bogaards JA; King AJ; Leussink S; van der Sande MA; Hoebe CJ; van Benthem BH;
Int J Cancer; 2019 Jun; 144(11):2718-2727. PubMed ID: 30426502
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of oral human papillomavirus by vaccination status among young adults (18-30years old).
Hirth JM; Chang M; Resto VA;
Vaccine; 2017 Jun; 35(27):3446-3451. PubMed ID: 28526331
[TBL] [Abstract][Full Text] [Related]
13. Behavioral, immunologic, and virologic correlates of oral human papillomavirus infection in HIV-infected youth.
Kahn JA; Rudy BJ; Xu J; Secord EA; Kapogiannis BG; Thornton S; Gillison ML
Sex Transm Dis; 2015 May; 42(5):246-52. PubMed ID: 25868136
[TBL] [Abstract][Full Text] [Related]
14. Effect of vaccination against oral HPV-16 infection in high school students in the city of Cali, Colombia.
Castillo A; Osorio JC; Fernández A; Méndez F; Alarcón L; Arturo G; Herrero R; Bravo LE
Papillomavirus Res; 2019 Jun; 7():112-117. PubMed ID: 30851448
[TBL] [Abstract][Full Text] [Related]
15. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
[TBL] [Abstract][Full Text] [Related]
16. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
Goggin P; Sauvageau C; Gilca V; Defay F; Lambert G; Mathieu-C S; Guenoun J; Comète E; Coutlée F
Hum Vaccin Immunother; 2018 Jan; 14(1):118-123. PubMed ID: 29049007
[TBL] [Abstract][Full Text] [Related]
17. Increasing Human Papillomavirus Vaccine Coverage Among Men Who Have Sex With Men-National HIV Behavioral Surveillance, United States, 2014.
Oliver SE; Hoots BE; Paz-Bailey G; Markowitz LE; Meites E;
J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3(Suppl 3):S370-S374. PubMed ID: 28604441
[TBL] [Abstract][Full Text] [Related]
18. Monitoring for Human Papillomavirus Vaccine Impact Among Gay, Bisexual, and Other Men Who Have Sex With Men-United States, 2012-2014.
Meites E; Gorbach PM; Gratzer B; Panicker G; Steinau M; Collins T; Parrish A; Randel C; McGrath M; Carrasco S; Moore J; Zaidi A; Braxton J; Kerndt PR; Unger ER; Crosby RA; Markowitz LE
J Infect Dis; 2016 Sep; 214(5):689-96. PubMed ID: 27296847
[TBL] [Abstract][Full Text] [Related]
19. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010.
Markowitz LE; Hariri S; Lin C; Dunne EF; Steinau M; McQuillan G; Unger ER
J Infect Dis; 2013 Aug; 208(3):385-93. PubMed ID: 23785124
[TBL] [Abstract][Full Text] [Related]
20. Human Papillomavirus (HPV) Vaccine Effectiveness and Potential Herd Immunity for Reducing Oncogenic Oropharyngeal HPV-16 Prevalence in the United Kingdom: A Cross-sectional Study.
Mehanna H; Bryant TS; Babrah J; Louie K; Bryant JL; Spruce RJ; Batis N; Olaleye O; Jones J; Struijk L; Molijn A; Vorsters A; Rosillon D; Taylor S; D'Souza G
Clin Infect Dis; 2019 Sep; 69(8):1296-1302. PubMed ID: 30590469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
